700 related articles for article (PubMed ID: 33193102)
1. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
2. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
3. Islet inflammation and CXCL10 in recent-onset type 1 diabetes.
Roep BO; Kleijwegt FS; van Halteren AG; Bonato V; Boggi U; Vendrame F; Marchetti P; Dotta F
Clin Exp Immunol; 2010 Mar; 159(3):338-43. PubMed ID: 20059481
[TBL] [Abstract][Full Text] [Related]
4. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
5. Insulin and type 1 diabetes: immune connections.
Culina S; Brezar V; Mallone R
Eur J Endocrinol; 2013 Feb; 168(2):R19-31. PubMed ID: 23065992
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
[TBL] [Abstract][Full Text] [Related]
7. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
9. Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes.
Bender C; Christen S; Scholich K; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
Diabetes; 2017 Jan; 66(1):113-126. PubMed ID: 27797910
[TBL] [Abstract][Full Text] [Related]
10. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
11. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
Hampe CS
Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
[TBL] [Abstract][Full Text] [Related]
12. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.
Ling Q; Shen L; Zhang W; Qu D; Wang H; Wang B; Liu Y; Lu J; Zhu D; Bi Y
Mol Med; 2022 Feb; 28(1):18. PubMed ID: 35123388
[TBL] [Abstract][Full Text] [Related]
13. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
[TBL] [Abstract][Full Text] [Related]
14. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.
Pietropaolo M; Towns R; Eisenbarth GS
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028135
[TBL] [Abstract][Full Text] [Related]
15. Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.
Christen S; Holdener M; Beerli C; Thoma G; Bayer M; Pfeilschifter JM; Hintermann E; Zerwes HG; Christen U
Clin Exp Immunol; 2011 Sep; 165(3):318-28. PubMed ID: 21649647
[TBL] [Abstract][Full Text] [Related]
16. Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
Bender C; Müller P; Tondello C; Horn J; Holdener M; Lasch S; Bayer M; Pfeilschifter JM; Tacke F; Ludwig A; Hansmann ML; Döring C; Hintermann E; Christen U
J Autoimmun; 2024 Feb; 143():103161. PubMed ID: 38141419
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes.
Uno S; Imagawa A; Saisho K; Okita K; Iwahashi H; Hanafusa T; Shimomura I
Endocr J; 2010; 57(11):991-6. PubMed ID: 20966598
[TBL] [Abstract][Full Text] [Related]
18. CD11c
Sandor AM; Lindsay RS; Dyjack N; Whitesell JC; Rios C; Bradley BJ; Haskins K; Serreze DV; Geurts AM; Chen YG; Seibold MA; Jacobelli J; Friedman RS
Front Immunol; 2019; 10():99. PubMed ID: 30766536
[TBL] [Abstract][Full Text] [Related]
19. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
20. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development.
Rhode A; Pauza ME; Barral AM; Rodrigo E; Oldstone MB; von Herrath MG; Christen U
J Immunol; 2005 Sep; 175(6):3516-24. PubMed ID: 16148094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
